| P50 | author | Yukihiro Fujita | Q90727506 |
| | Masakazu Haneda | Q96024993 |
| P2093 | author name string | Hidemitsu Sakagami | |
| | Jun Honjo | |
| | Tsuyoshi Yanagimachi | |
| | Yasutaka Takeda | |
| | Hiroki Yokoyama | |
| | Nobuhiro Maruyama | |
| | Ryoichi Bessho | |
| P2860 | cites work | Biology of incretins: GLP-1 and GIP | Q29617302 |
| | Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion | Q33529942 |
| | Preparation of highly active enterogastrone | Q34054149 |
| | Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains | Q36721554 |
| | Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects | Q37613876 |
| | Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans | Q39221120 |
| | Is GIP a glucagon cell constituent? | Q39644709 |
| | Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (1-30) expression is upregulated in diabetes and PEGylated GIP(1-30) can suppress the progression of low-dose-STZ-induced hyperglycaemia in mice | Q40181768 |
| | Prohormone convertase 1/3 is essential for processing of the glucose-dependent insulinotropic polypeptide precursor | Q40316756 |
| | Immunocytochemical localization of a gastric inhibitory polypeptide-like material within A-cells of the endocrine pancreas | Q40815912 |
| | Characterization of GIP(1-30) and GIP(1-42) as stimulators of proinsulin gene transcription | Q41387552 |
| | Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes | Q42204919 |
| | Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans | Q42464329 |
| | GIP-like immunoreactivity in glucagon cells. Interactions between GIP and glucagon on insulin release | Q42467330 |
| | Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans | Q42487199 |
| | Differential processing of pro-glucose-dependent insulinotropic polypeptide in gut. | Q43149045 |
| | Comparison of sub-chronic metabolic effects of stable forms of naturally occurring GIP(1-30) and GIP(1-42) in high-fat fed mice. | Q51382417 |
| | Evidence of Extrapancreatic Glucagon Secretion in Man | Q58447369 |
| | Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man | Q68813361 |
| | Stimulation of insulin secretion by gastric inhibitory polypeptide in man | Q69602585 |
| | Further purification of a polypeptide demonstrating enterogastrone activity | Q71641508 |
| | A comparison of the ability of serum and monoclonal antibodies to gastric inhibitory polypeptide to detect immunoreactive cells in the gastroenteropancreatic system of mammals and reptiles | Q72689816 |
| P433 | issue | 11 | |
| P304 | page(s) | e14469 | |
| P577 | publication date | 2020-06-01 | |
| P1433 | published in | Physiological Reports | Q15716763 |
| P1476 | title | Establishment of novel specific assay for short-form glucose-dependent insulinotropic polypeptide and evaluation of its secretion in nondiabetic subjects | |
| P478 | volume | 8 | |